Showing 851-860 of 3260 results for "".
Find Your Niche
https://practicaldermatology.com/topics/practice-management/find-your-niche-1/20268/Learn what you’re good at and what you have a passion for and then start channeling your career and education in that direction, Hilary Baldwin, MD recommends. She says finding an area of focus and expertise is a key to finding satisfaction and happiness at work.Toxic Attitudes Toward Skin Bleaching
https://practicaldermatology.com/conferences/aad-2021/toxic-attitudes-toward-skin-bleaching/19925/Unregulated ingredients intended for skin lightening and bleaching range from the toxic to the simply unproven. Seemal Desai, MD says dermatologists should educate patients about physician-recommended, well-studied treatments and the risks of unregulated products. He highlights increased attention tThe Skin Cancer Foundation at 40
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-skin-cancer-foundation-at-40/19614/Skin Cancer Foundation president Deborah Sarnoff, MD talks about the Foundation's accomplishments, its current focus, and future goals. Founded in 1979, the foundation has helped educate the public on skin cancer risk and supports dermatologists in practice.Effective Communication: Achieve Results You Want
https://practicaldermatology.com/topics/practice-management/effective-communication-achieve-results-you-want/19593/Kalyani Marathe, MD describes the Path to Action plan that can help you improve your communication skills—whether you're presenting, consulting with colleagues, or talking to patients. She offers tips for assessing your skills and finding ways to change your approach when needed.Exploring the Complexities of Psoriasis
https://practicaldermatology.com/topics/psoriasis/exploring-the-complexities-of-psoriasis/18553/Biologic therapies developed over the last decade or more to treat psoriasis may do more than clear the skin. Researchers are investigating the effects of treatment on comorbid risks, and comparing treatment with older interventions. Jashin Wu, MD explains.Systemic Implications of Psoriasis
https://practicaldermatology.com/topics/psoriasis/systemic-implications-of-psoriasis/18636/Although a disease with a presentation on the skin, psoriasis has important implications for systemic health. Joel Gelfand, MD, talks about the increased risk for diabetes and cardiovascular disease in patients with psoriasis, as well as the clinician's role in educating patients about their diseaseMy New Favorite Thing: Budget-free Consults
https://practicaldermatology.com/topics/practice-management/my-new-favorite-thing-budget-free-consults/19043/Don't let budget concerns limit the patient consult. Steve Yoelin, MD says that the patient evaluation and consult should focus on the patient's concerns and the physician's expertise about how to address those. Then the conversation can move toward devising a regimen that fits the patient's budgetDermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
https://practicaldermatology.com/topics/skin-of-color/dermwire-tv-extra-dr-ruiz-gep-testing-scc/29497/Emily Ruiz, MD, MPH, FAAD, a Mohs surgeon at Brigham and Women's Hospital and cutaneous oncologist at Dana-Farber Cancer Institute, discusses her recent Future Oncology article, "Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile."Updates in Vulvar Dermatology
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/updates-in-vulvar-dermatology/33012/Melissa Mauskar, MD, an associate professor and director of the vulvar heatlh program at UT Southwestern Medical Center, talks about the importance of having dermatologists promote vulvar health and regular examination, while also working to reduce patient anxiety.PsA-5T-Ds: A New Psoriatic Arthritis Assessment Tool
https://practicaldermatology.com/topics/psoriasis/psa-5t-ds-a-new-psoriatic-arthritis-assessment-tool/20227/The PsA 5-Thermometer Scale Domains (PsA-5T-Ds) measures patient-reported pain, fatigue, physical function, skin problems, and depression. Here, Philip Mease, MD, discusses the validity of this tool in three Phase 3 studies of guselkumab as well as the role it could play in practice.